In this study, data from the GEO and TCGA databases demonstrated significantly higher levels of visfatin and VEGF-C expression in ESCC tissue samples compared with levels in adjacent normal tissue, and positive correlations were observed between visfatin and VEGF-C expression with ESCC clinical disease stages. This evidence concerns the gene NAMPT and esophageal squamous cell carcinoma.